Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

Delayed Data
As of Sep 23
 -0.05 / -2.31%
Today’s Change
Today|||52-Week Range
5 Biotech Stocks to Watch as Interest in NASH Increases
Sep 22 / Zacks.com - Paid Partner Content
Here's Why Conatus Pharmaceuticals (CNAT) Stock Is Soaring Today
Sep 20 / TheStreet.com - Paid Partner Content
Biotech ETFs in Focus on Tobira Therapeutics' Massive Gain
Sep 21 / Zacks.com - Paid Partner Content
These Biotech Names Are on My Radar
Sep 20 / TheStreet.com - Paid Partner Content